Corteva, Inc. $CTVA Shares Sold by Richard Bernstein Advisors LLC

Richard Bernstein Advisors LLC lowered its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 62.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,413 shares of the company’s stock after selling 32,867 shares during the period. Richard Bernstein Advisors LLC’s holdings in Corteva were worth $1,313,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Bank of Montreal Can lifted its position in Corteva by 3.0% during the third quarter. Bank of Montreal Can now owns 678,799 shares of the company’s stock valued at $45,907,000 after buying an additional 19,478 shares in the last quarter. Legal & General Group Plc boosted its position in Corteva by 14.3% in the 3rd quarter. Legal & General Group Plc now owns 5,753,982 shares of the company’s stock valued at $389,142,000 after buying an additional 720,469 shares during the last quarter. Banque Cantonale Vaudoise grew its stake in Corteva by 41.6% during the 3rd quarter. Banque Cantonale Vaudoise now owns 4,110 shares of the company’s stock valued at $278,000 after purchasing an additional 1,208 shares in the last quarter. Fieldview Capital Management LLC bought a new stake in shares of Corteva in the third quarter worth $4,790,000. Finally, WINTON GROUP Ltd acquired a new stake in shares of Corteva in the 3rd quarter valued at about $5,704,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. Citigroup upped their price objective on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Argus upgraded shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Finally, Royal Bank Of Canada lifted their price target on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and a consensus price target of $82.90.

Insider Buying and Selling

In other news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.15% of the stock is currently owned by corporate insiders.

Corteva Price Performance

Shares of Corteva stock opened at $76.30 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm has a fifty day simple moving average of $73.40 and a 200-day simple moving average of $69.06. The stock has a market capitalization of $51.31 billion, a price-to-earnings ratio of 48.29, a PEG ratio of 2.68 and a beta of 0.72. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.